Could a simple blood test predict newborn risks in diabetic pregnancies?

This study explores whether alternative biomarkers, such as glycated albumin and glycated serum protein, can better track glucose control in pregnant women with diabetes and predict the risk of complications in their newborns. Researchers will collect blood samples from participants at multiple points during pregnancy and compare these biomarkers to standard measures of glucose control and neonatal outcomes. The goal is to gather preliminary data that could lead to improved monitoring and prediction of adverse events in this high-risk population.